We are live on
!
Find out more
UFF
USA Financial Formulas Portfolio holdings
AUM
$546M
1-Year Est. Return
39.63%
This Fund
S&P 500
This Quarter
Est. Return
+5.26%
1 Year Est. Return
+39.63%
3 Year Est. Return
+98.91%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$61.7M
AUM Growth
–
Cap. Flow
+$61.1M
Cap. Flow
% of AUM
98.96%
Top 10 Holdings %
Top 10 Hldgs %
41.2%
Holding
424
New
424
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$3.45M |
| 2 |
Gilead Sciences
GILD
|
+$3.41M |
| 3 |
Ross Stores
ROST
|
+$3.25M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$3.18M |
| 5 |
FISV
Fiserv Inc
FISV
|
+$3.04M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 27.73% |
| 2 | Industrials | 12.07% |
| 3 | Consumer Discretionary | 11.44% |
| 4 | Energy | 9.58% |
| 5 | Consumer Staples | 8.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Biogen
BIIB
$32.6B
| $3.47M | 5.62% |
+12,485
| New | +$3.45M |
|
|
2
Gilead Sciences
GILD
$187B
| $3.41M | 5.53% |
+41,119
| New | +$3.41M |
|
|
3
Vertex Pharmaceuticals
VRTX
$138B
| $3.34M | 5.42% |
+10,614
| New | +$3.18M |
|
4
Regeneron Pharmaceuticals
REGN
$85.2B
| $3.28M | 5.31% |
+3,988
| New | +$3.01M |
|
|
FISV
5
Fiserv Inc
FISV
$28.2B
| $3.13M | 5.07% |
+27,665
| New | +$3.04M |
|
|
6
Ross Stores
ROST
$73.7B
| $3.07M | 4.98% |
+28,939
| New | +$3.25M |
|
7
Monster Beverage
MNST
$85.8B
| $2.34M | 3.79% |
+86,716
| New | +$2.22M |
|
8
Merck
MRK
$371B
| $1.19M | 1.93% |
+11,219
| New | +$1.21M |
|
9
Cummins
CMI
$77.2B
| $1.1M | 1.78% |
+4,610
| New | +$1.13M |
|
10
Lamb Weston
LW
$6.86B
| $1.09M | 1.77% |
+10,427
| New | +$1.03M |
|
11
Arch Capital
ACGL
$33.5B
| $1.07M | 1.73% |
+15,748
| New | +$1.03M |
|
12
Ulta Beauty
ULTA
$24.1B
| $1.05M | 1.71% |
+1,929
| New | +$990K |
|
13
Marathon Petroleum
MPC
$109B
| $1.04M | 1.69% |
+7,723
| New | +$966K |
|
14
Boston Scientific
BSX
$69.3B
| $1.03M | 1.67% |
+20,596
| New | +$971K |
|
15
PG&E
PCG
$31.5B
| $1.02M | 1.66% |
+63,288
| New | +$1,000K |
|
16
Conagra Brands
CAG
$7.43B
| $1.01M | 1.64% |
+26,977
| New | +$1,000K |
|
17
ExxonMobil
XOM
$656B
| $989K | 1.6% |
+9,021
| New | +$998K |
|
18
TJX Companies
TJX
$145B
| $982K | 1.59% |
+12,526
| New | +$986K |
|
19
IDEX
IEX
$16.5B
| $977K | 1.58% |
+4,231
| New | +$960K |
|
20
Globe Life
GL
$13.4B
| $953K | 1.54% |
+8,659
| New | +$1.02M |
|
21
BorgWarner
BWA
$13.8B
| $944K | 1.53% |
+21,841
| New | +$904K |
|
22
Willis Towers Watson
WTW
$31.1B
| $938K | 1.52% |
+4,036
| New | +$976K |
|
23
Air Products & Chemicals
APD
$67.1B
| $936K | 1.52% |
+3,259
| New | +$951K |
|
24
Steel Dynamics
STLD
$34.7B
| $900K | 1.46% |
+7,961
| New | +$925K |
|
25
Valero Energy
VLO
$107B
| $877K | 1.42% |
+6,282
| New | +$844K |
|
Similar funds
HW
LF
AAM
QAM
SCM
TGAM
DBG
BF
USA Financial Formulas's Q1 2023 Portfolio in Review
As of Q1 2023, USA Financial Formulas held 424 positions worth $61.7M. Its ten largest holdings account for 41% of the portfolio.
USA Financial Formulas deployed $61.1M of net new capital in Q1 2023, opening 424 new positions. Its largest new stake was Biogen: 12,485 shares worth $3.47M.
By sector, the portfolio is most concentrated in Healthcare at 28% of assets, followed by Industrials and Consumer Discretionary.
- USA Financial Formulas's largest Q1 2023 buy was Biogen: 12,485 shares worth $3.47M.
- USA Financial Formulas's ten largest holdings make up 41% of its $61.7M portfolio in Q1 2023.
- USA Financial Formulas opened 424 new positions and closed 0 in Q1 2023.
Based on USA Financial Formulas's 13F filing for Q1 2023, filed 27 Nov 2023.